ProfileGDS4132 / 221894_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 86% 89% 88% 91% 86% 85% 86% 84% 83% 85% 84% 85% 86% 90% 85% 81% 85% 83% 85% 85% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101335.48886
GSM201543Muscle PCOS pioglitazone 121358.18689
GSM201544Muscle PCOS pioglitazone 161415.07988
GSM201545Muscle PCOS pioglitazone 201493.60991
GSM201829Muscle PCOS pioglitazone 231358.33386
GSM201830Muscle PCOS pioglitazon 251327.10785
GSM201831Muscle PCOS pioglitazone 271350.96986
GSM201832Muscle PCOS pioglitazone 31311.62884
GSM201833Muscle PCOS pioglitazone 41305.69183
GSM201834Muscle PCOS pioglitazone 81336.52185
GSM201835Muscle PCOS after pioglitazone 102331.05984
GSM201836Muscle PCOS after pioglitazone 122344.68885
GSM201837Muscle PCOS after pioglitazone 162342.81786
GSM201838Muscle PCOS after pioglitazone 202503.76590
GSM201839Muscle PCOS after pioglitazone 232354.15485
GSM201840Muscle PCOS after pioglitazone 252308.12781
GSM201841Muscle PCOS after pioglitazone 272335.33885
GSM201842Muscle PCOS after pioglitazone 32292.39183
GSM201843Muscle PCOS after pioglitazone 42332.21985
GSM201844Muscle PCOS after pioglitazone 82347.93485